Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium Channels, N-Type | 9 | 2018 | 11 | 2.550 |
Why?
|
| Calcium Channels, L-Type | 7 | 2018 | 26 | 2.140 |
Why?
|
| Receptor, Muscarinic M1 | 7 | 2018 | 8 | 1.830 |
Why?
|
| Neurons | 10 | 2018 | 940 | 1.590 |
Why?
|
| Calcium Channels | 5 | 2015 | 104 | 1.250 |
Why?
|
| Calcium Signaling | 3 | 2018 | 165 | 1.110 |
Why?
|
| Calcium | 6 | 2018 | 583 | 0.980 |
Why?
|
| Membrane Potentials | 6 | 2018 | 138 | 0.860 |
Why?
|
| Oxotremorine | 5 | 2018 | 6 | 0.820 |
Why?
|
| Superior Cervical Ganglion | 7 | 2009 | 9 | 0.770 |
Why?
|
| Protein Subunits | 4 | 2009 | 169 | 0.720 |
Why?
|
| Rats | 12 | 2018 | 1996 | 0.670 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 3 | 2009 | 17 | 0.620 |
Why?
|
| Arachidonic Acid | 4 | 2009 | 38 | 0.620 |
Why?
|
| Group IV Phospholipases A2 | 1 | 2018 | 5 | 0.590 |
Why?
|
| Sympathetic Nervous System | 1 | 2018 | 35 | 0.570 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 138 | 0.530 |
Why?
|
| Calcium Channel Blockers | 5 | 2009 | 58 | 0.510 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2016 | 14 | 0.500 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2018 | 623 | 0.460 |
Why?
|
| Receptors, Dopamine | 1 | 2015 | 16 | 0.460 |
Why?
|
| Signal Transduction | 5 | 2015 | 3148 | 0.450 |
Why?
|
| Cholesterol | 1 | 2016 | 261 | 0.450 |
Why?
|
| Triglycerides | 1 | 2016 | 248 | 0.440 |
Why?
|
| Corpus Striatum | 1 | 2015 | 98 | 0.430 |
Why?
|
| GABA-B Receptor Agonists | 1 | 2014 | 1 | 0.420 |
Why?
|
| Baclofen | 1 | 2014 | 2 | 0.420 |
Why?
|
| Calcium Channels, R-Type | 1 | 2014 | 2 | 0.420 |
Why?
|
| Conotoxins | 1 | 2014 | 3 | 0.420 |
Why?
|
| Cation Transport Proteins | 1 | 2014 | 22 | 0.410 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2009 | 10 | 0.390 |
Why?
|
| Animals | 19 | 2019 | 21310 | 0.360 |
Why?
|
| Receptors, Muscarinic | 3 | 2009 | 18 | 0.340 |
Why?
|
| Muscarinic Agonists | 3 | 2008 | 8 | 0.320 |
Why?
|
| Receptors, Tachykinin | 1 | 2009 | 2 | 0.310 |
Why?
|
| Neural Inhibition | 2 | 2006 | 30 | 0.300 |
Why?
|
| Lipoprotein Lipase | 1 | 2008 | 13 | 0.280 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2008 | 31 | 0.280 |
Why?
|
| Ion Channel Gating | 1 | 2008 | 44 | 0.280 |
Why?
|
| Electric Stimulation | 1 | 2007 | 139 | 0.250 |
Why?
|
| Potassium Channels | 1 | 2006 | 55 | 0.250 |
Why?
|
| Lipids | 1 | 2009 | 327 | 0.250 |
Why?
|
| Patch-Clamp Techniques | 4 | 2008 | 133 | 0.240 |
Why?
|
| Cells, Cultured | 4 | 2009 | 2188 | 0.210 |
Why?
|
| Phospholipids | 1 | 2004 | 81 | 0.200 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 2003 | 1 | 0.200 |
Why?
|
| Receptor, Muscarinic M4 | 1 | 2003 | 2 | 0.200 |
Why?
|
| Bethanechol | 1 | 2003 | 4 | 0.200 |
Why?
|
| Egtazic Acid | 1 | 2003 | 8 | 0.200 |
Why?
|
| Pyrroles | 1 | 2003 | 49 | 0.200 |
Why?
|
| Muscarinic Antagonists | 1 | 2002 | 34 | 0.190 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1633 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 430 | 0.170 |
Why?
|
| Pertussis Toxin | 3 | 2008 | 14 | 0.170 |
Why?
|
| Insulin-Secreting Cells | 3 | 2019 | 193 | 0.160 |
Why?
|
| Cell Line | 3 | 2015 | 2036 | 0.160 |
Why?
|
| Endocrine Cells | 1 | 2019 | 10 | 0.160 |
Why?
|
| Electric Conductivity | 2 | 2009 | 52 | 0.150 |
Why?
|
| Animals, Newborn | 3 | 2006 | 241 | 0.150 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2018 | 22 | 0.140 |
Why?
|
| HEK293 Cells | 2 | 2018 | 616 | 0.140 |
Why?
|
| Reaction Time | 1 | 2018 | 127 | 0.140 |
Why?
|
| Islets of Langerhans | 1 | 2019 | 283 | 0.140 |
Why?
|
| Drug Interactions | 2 | 2007 | 124 | 0.120 |
Why?
|
| Electrophysiology | 2 | 2008 | 89 | 0.120 |
Why?
|
| Transcriptome | 1 | 2019 | 396 | 0.120 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 1285 | 0.120 |
Why?
|
| Phospholipase C beta | 1 | 2015 | 1 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 46 | 0.120 |
Why?
|
| Lysosomes | 1 | 2016 | 171 | 0.120 |
Why?
|
| Spleen | 1 | 2016 | 476 | 0.110 |
Why?
|
| Hepatocytes | 1 | 2016 | 222 | 0.110 |
Why?
|
| Spectrum Analysis | 1 | 2014 | 50 | 0.110 |
Why?
|
| Models, Biological | 2 | 2009 | 1203 | 0.110 |
Why?
|
| Humans | 11 | 2019 | 64778 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 687 | 0.100 |
Why?
|
| Pancreas | 1 | 2014 | 154 | 0.100 |
Why?
|
| Mice | 4 | 2019 | 11100 | 0.100 |
Why?
|
| Cilia | 1 | 2014 | 156 | 0.090 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2012 | 3 | 0.090 |
Why?
|
| 14-3-3 Proteins | 1 | 2012 | 20 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 2012 | 102 | 0.090 |
Why?
|
| Liver | 1 | 2016 | 867 | 0.090 |
Why?
|
| Cerebellum | 1 | 2012 | 94 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2277 | 0.090 |
Why?
|
| Endocytosis | 1 | 2012 | 153 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1031 | 0.090 |
Why?
|
| Macrophages | 1 | 2016 | 1048 | 0.080 |
Why?
|
| Palmitic Acid | 1 | 2009 | 14 | 0.080 |
Why?
|
| Lipoylation | 1 | 2009 | 5 | 0.080 |
Why?
|
| Phospholipases A2, Cytosolic | 1 | 2009 | 1 | 0.080 |
Why?
|
| Cyclohexanones | 1 | 2008 | 4 | 0.070 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2008 | 4 | 0.070 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2008 | 4 | 0.070 |
Why?
|
| Arachidonic Acids | 1 | 2008 | 27 | 0.070 |
Why?
|
| Vasodilation | 1 | 2008 | 36 | 0.070 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2008 | 32 | 0.070 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 215 | 0.070 |
Why?
|
| Rats, Wistar | 1 | 2008 | 182 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2008 | 61 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 106 | 0.070 |
Why?
|
| CREB-Binding Protein | 1 | 2007 | 15 | 0.060 |
Why?
|
| Phospholipases A | 1 | 2006 | 15 | 0.060 |
Why?
|
| Potassium Channel Blockers | 1 | 2006 | 23 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2006 | 39 | 0.060 |
Why?
|
| Serine | 1 | 2007 | 90 | 0.060 |
Why?
|
| Potassium | 1 | 2007 | 97 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 710 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 543 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 364 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 897 | 0.050 |
Why?
|
| Phospholipases | 1 | 2004 | 9 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2007 | 960 | 0.050 |
Why?
|
| Lysophospholipids | 1 | 2004 | 26 | 0.050 |
Why?
|
| Calcium Channel Agonists | 1 | 2003 | 11 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2003 | 27 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2004 | 94 | 0.050 |
Why?
|
| Nimodipine | 1 | 2002 | 2 | 0.050 |
Why?
|
| Kinetics | 1 | 2004 | 758 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2006 | 2152 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1572 | 0.040 |
Why?
|
| Time Factors | 1 | 2007 | 3753 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 240 | 0.040 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2019 | 178 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 206 | 0.040 |
Why?
|
| Graft Survival | 1 | 2019 | 297 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 792 | 0.030 |
Why?
|
| Insulin | 1 | 2019 | 692 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2015 | 33 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 74 | 0.030 |
Why?
|
| Surface Properties | 1 | 2014 | 284 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2015 | 275 | 0.020 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2012 | 33 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 156 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 409 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4773 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 729 | 0.020 |
Why?
|
| Adult | 1 | 2019 | 17243 | 0.010 |
Why?
|
| Male | 1 | 2019 | 30812 | 0.010 |
Why?
|
| Female | 1 | 2019 | 33765 | 0.010 |
Why?
|